Emitido el jueves, 9 de abril 2020 · 14.00 h UTC/GMT
Thrombosis, Thromboprophylaxis and Coagulopathy in COVID- 19 Infections
Professor @University College Hospital
Marcel Levi is consultant physician at UCLH. After his medical training and specialization in Internal Medicine at the University of Amsterdam he obtained his PhD with honours (1991) and was appointed as a Fellow by the Royal Netherlands Academy of Science. He has also worked at the University of Perugia, Italy and the Center for Transgene Technology and Genetherapy of the University of Leuven, Belgium. Marcel Levi’s key interests are general medicine, acute medicine, hemostasis (blood clotting) and thrombosis, vascular medicine, and angio-edema. He has published more than 700 articles in international scientific journals, has been awarded several international research awards, and serves as an associate editor for many international scientific journals. He was elected as a member of the Royal Netherlands Academy of Science (KNAW) and a fellow of the Royal College of Physicians in the UK. Prof. Levi will be discussing «Coagulopathy in COVID-19 Infections» during the webinar.
Beverley Jane Hunt
Professor of Thrombosis & Haemostasis @King’s College London
Clinical & laboratory: She has a large clinical practice, specialising in thrombosis and haemostasis & obstetric haematology. She leads on the management of thrombosis within GSTT. She set up the GSTT award-winning “Thrombosis” app – thrombosis management in elegant algorithms Her laboratory work includes sitting on the board of Viapath LLP and leading in all aspects of haematological laboratory work. Research & Development: She runs a research group with over 350 peer-reviewed publications to her name, and won the BMJ Research paper of the year 2011 with the CRASH-2 team. Prof. Hunt will be discussing «Thrombosis and Anticoagulant Management in COVID-19 Infections».
Professor @John Radcliffe Hospital
Professor Simon J. Stanworth is a Consultant Haematologist at the John Radcliffe Hospital for NHS Blood & Transplant and Oxford University Hospitals NHS Foundation Trust, and the University of Oxford. His research interests are centered on clinical indications of blood components and use of alternatives, including large pragmatic clinical trials as treatment of bleeding or prophylaxis. He is Chair of the Specialty Working Group for Transfusion for the European Haematology Association, vice Chair for the International Committee Transfusion Medicine Guidelines (ICTMG), and Secretary of the Regional Transfusion Committee for Oxford and Southampton/Hants.
- Simon Stanworth, Ph.D., John Radcliffe Hospital (U.K.)